SOLV Solventum Corporation

NYSE
$88.59

Solventum Corporation (SOLV) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $1.40 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.1% since its last earnings release on August 5, 2026.

Solventum Beat Consensus Estimates, Raises Guidance
Wednesday, August 5, 2026 · 4:12 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $1.40
Rev est $2B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $84.98

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Solventum Corporation

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

Sector

Healthcare

Industry

Medical Instruments/Supply